Cargando…
Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target
Transitional cell carcinoma (TCC) is the most common malignant tumor of the canine urinary tract and tends to have a poor prognosis due to its invasive potential. Recent studies have reported that up to 80% of canine urothelial carcinoma has the BRAF V595E mutation, which is homologous to the human...
Autores principales: | Jung, Hyojik, Bae, Kieun, Lee, Ja Young, Kim, Jung-Hyun, Han, Hyun-Jung, Yoon, Hun-Young, Yoon, Kyong-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430554/ https://www.ncbi.nlm.nih.gov/pubmed/34502061 http://dx.doi.org/10.3390/ijms22179151 |
Ejemplares similares
-
Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib)
por: Kim, Jung-Hyun, et al.
Publicado: (2021) -
Case report: Adjuvant therapy with toceranib for an incompletely resected renal cell carcinoma with suspected pulmonary metastasis in a dog
por: Lee, Da-Eun, et al.
Publicado: (2023) -
Correlation of BRAF Variant V595E, Breed, Histological Grade and Cyclooxygenase-2 Expression in Canine Transitional Cell Carcinomas
por: Grassinger, Julia M., et al.
Publicado: (2019) -
Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
por: Kim, Sang-Won, et al.
Publicado: (2023) -
Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs
por: Yamasaki, Hirofumi, et al.
Publicado: (2022)